Skip to main content
. 2020 Dec 3;27(2):236–245. doi: 10.3350/cmh.2020.0204

Figure 1.

Figure 1.

Barcelona Clinic Liver Cancer (BCLC) staging and treatment strategy. Modified from Forner et al. [8] with permission from Elsevier. HCC, hepatocellular carcinoma; ECOG, Eastern Cooperative Oncology Group; PS, performance status; BSC, best supportive care. *Currently, sorafenib followed by regorafenib has been shown to be effective. Lenvatinib has been shown to be non-inferior to sorafenib, but no second-line option after Lenvatinib has been explored.